Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Superior Parietal iTBS for PD-MCI

NCT: NCT07701785 · RECRUITING

NCT IDNCT07701785
StatusRECRUITING
Start Date2026-10-09
Completion2028-04-30
SponsorMedical University of South Carolina (OTHER)
First posted
Last updated

Brief Summary

The goal of this study is to determine the whether a short-term, high-dose form of non-invasive brain stimulation (intermittent theta burst stimulation; iTBS) is a promising and safe treatment for mild cognitive impairment in Parkinson's disease (PD-MCI).

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑